PR Newswire | Nov 24, 2020 08:01AM EST

11/24 07:00 CST

Insmed to Present at the Evercore ISI 3rd Annual HealthCONx Conference BRIDGEWATER, N.J., Nov. 24, 2020

BRIDGEWATER, N.J., Nov. 24, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the virtual Evercore ISI 3rd Annual HealthCONx Conference on Tuesday, December 1, 2020 at 8:00 a.m. ET.

The fireside chat will be webcast live and can be accessed by visiting the investor relations section of the company's website at www.insmed.com. The webcast will be archived for a period of 30 days following the conclusion of the live event.

About Insmed

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States and the European Union to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing footprint across Europe and in Japan. For more information, visit www.insmed.com.

Contact:

Investors:

Argot Partners Laura Perry or Heather Savelle(212) 600-1902 Insmed@argotpartners.com

Media:

Mandy FaheySenior Director, Corporate Communications Insmed (732) 718-3621 amanda.fahey@insmed.com

View original content to download multimedia: http://www.prnewswire.com/news-releases/insmed-to-present-at-the-evercore-isi-3rd-annual-healthconx-conference-301178239.html

SOURCE Insmed Incorporated